Skip to main content

Table 1 Patient characteristics based on SUA quartiles

From: Association between serum uric acid levels and bone mineral density in patients with osteoporosis: a cross-sectional study

Characteristics

Total

Mean ± SD / N (%)

P-value

P-value*

Q1(< 231 μmol/L)

Q2(231–278 μmol/L)

Q3(278–341 μmol/L)

Q4(> 341 μmol/L)

N

1249

311

311

313

314

  

BMD, g/cm2

0.76 ± 0.14

0.71 ± 0.12

0.75 ± 0.13

0.78 ± 0.14

0.80 ± 0.15

 < 0.001

 < 0.001

Age, y

67.94 ± 9.61

68.28 ± 8.69

66.90 ± 9.61

67.74 ± 9.31

68.83 ± 10.66

0.076

0.053

Platelet count, × 109/L

185.12 ± 61.04

185.08 ± 64.99

191.84 ± 58.52

181.59 ± 53.16

181.98 ± 66.29

0.133

0.045

Neutrophil count, × 109/L

4.47 ± 2.35

4.38 ± 2.12

4.51 ± 2.42

4.35 ± 2.39

4.66 ± 2.44

0.355

0.206

Lymphocyte count, × 109/L

1.41 ± 0.56

1.27 ± 0.50

1.40 ± 0.54

1.48 ± 0.59

1.47 ± 0.58

 < 0.001

 < 0.001

Monocyte count, × 109/L

0.41 ± 0.19

0.40 ± 0.17

0.41 ± 0.18

0.40 ± 0.20

0.43 ± 0.20

0.168

0.257

Albumin, g/L

40.26 ± 4.75

39.76 ± 4.37

40.61 ± 4.65

40.58 ± 4.69

40.07 ± 5.21

0.070

0.013

Hemoglobin, g/L

124.20 ± 16.72

121.98 ± 18.46

125.07 ± 14.24

125.26 ± 14.39

124.47 ± 19.04

0.055

0.065

Calcium, mmol/L

2.27 ± 0.18

2.24 ± 0.22

2.27 ± 0.15

2.28 ± 0.13

2.28 ± 0.20

0.012

 < 0.001

ALT, U/L

21.14 ± 13.59

18.85 ± 10.84

20.56 ± 13.62

21.04 ± 11.96

24.09 ± 16.72

 < 0.001

 < 0.001

AST, U/L

23.82 ± 10.68

21.99 ± 8.27

23.37 ± 9.82

23.93 ± 9.93

25.96 ± 13.61

 < 0.001

0.002

Cr, μmol/L

61.39 ± 24.98

54.87 ± 19.63

55.32 ± 12.87

60.61 ± 18.73

74.66 ± 36.56

 < 0.001

 < 0.001

CRP, mg/L

1.66 ± 4.60

1.35 ± 3.10

1.75 ± 3.56

1.51 ± 3.49

2.05 ± 7.10

0.760

0.762

BUN, mmol/L

6.24 ± 1.82

5.76 ± 1.45

5.83 ± 1.45

6.33 ± 1.60

7.03 ± 2.33

 < 0.001

 < 0.001

Glucose, mmol/L

6.06 ± 1.95

6.32 ± 2.14

6.12 ± 2.01

5.88 ± 1.62

5.92 ± 1.96

0.019

0.041

Total cholesterol, mmol/L

4.58 ± 1.01

4.52 ± 1.04

4.71 ± 1.05

4.54 ± 0.95

4.56 ± 0.99

0.166

0.110

Triglyceride, mmol/L

1.38 ± 0.93

1.22 ± 1.12

1.30 ± 0.72

1.37 ± 0.82

1.60 ± 0.98

 < 0.001

 < 0.001

High-density lipoprotein, mmol/L

1.46 ± 0.33

1.50 ± 0.33

1.52 ± 0.33

1.45 ± 0.35

1.40 ± 0.30

 < 0.001

 < 0.001

Low-density lipoprotein, mmol/L

2.74 ± 0.81

2.63 ± 0.85

2.80 ± 0.79

2.71 ± 0.78

2.82 ± 0.80

0.056

0.040

Apolipoprotein A, g/L

1.38 ± 0.27

1.38 ± 0.27

1.42 ± 0.29

1.36 ± 0.27

1.35 ± 0.26

0.038

0.030

Apolipoprotein B, g/L

0.90 ± 0.24

0.87 ± 0.25

0.92 ± 0.24

0.89 ± 0.23

0.91 ± 0.23

0.085

0.076

Homocysteine, μmol/L

13.12 ± 6.80

11.34 ± 4.91

12.50 ± 7.03

12.88 ± 5.46

15.44 ± 8.39

 < 0.001

 < 0.001

25(OH)D levels, ng/mL

20.81 ± 8.19

18.52 ± 7.41

21.25 ± 8.20

20.89 ± 7.81

22.59 ± 8.79

 < 0.001

 < 0.001

Gender, N (%)

     

 < 0.001

-

 Male

233 (18.65%)

25 (8.04%)

46 (14.79%)

64 (20.45%)

98 (31.21%)

  

 Female

1016 (81.35%)

286 (91.96%)

265 (85.21%)

249 (79.55%)

216 (68.79%)

  

BMI categorical, N (%)

     

 < 0.001

-

  < 24 kg/m2

778 (62.29%)

223 (71.70%)

206 (66.24%)

186 (59.42%)

163 (51.91%)

  

  24–28 kg/m2

358 (28.66%)

75 (24.12%)

85 (27.33%)

100 (31.95%)

98 (31.21%)

  

  ≥ 28 kg/m2

113 (9.05%)

13 (4.18%)

20 (6.43%)

27 (8.63%)

53 (16.88%)

  

CCI score categorical, N (%)

     

0.197

-

 0

879 (70.38%)

234 (75.24%)

224 (72.03%)

209 (66.77%)

212 (67.52%)

  

 1–2

194 (15.53%)

47 (15.11%)

39 (12.54%)

53 (16.93%)

55 (17.52%)

  

 3–4

107 (8.57%)

17 (5.47%)

28 (9.00%)

34 (10.86%)

28 (8.92%)

  

  ≥ 5

69 (5.52%)

13 (4.18%)

20 (6.43%)

17 (5.43%)

19 (6.05%)

  

Calcitonin usage, N (%)

     

0.017

-

 No

973 (77.90%)

223 (71.70%)

243 (78.14%)

254 (81.15%)

253 (80.57%)

  

 Yes

276 (22.10%)

88 (28.30%)

68 (21.86%)

59 (18.85%)

61 (19.43%)

  

Surgery, N (%)

     

 < 0.001

-

 No

636 (50.92%)

119 (38.26%)

162 (52.09%)

179 (57.19%)

176 (56.05%)

  

 Yes

613 (49.08%)

192 (61.74%)

149 (47.91%)

134 (42.81%)

138 (43.95%)

  

Primary diagnosis, N (%)

     

 < 0.001

-

OP without fractures

771 (61.73%)

151 (48.55%)

193 (62.06%)

213 (68.05%)

214 (68.15%)

  

OPF

478 (38.27%)

160 (51.45%)

118 (37.94%)

100 (31.95%)

100 (31.85%)

  
  1. Abbreviations: SUA serum uric acid, SD standard deviation, Q1 first quartile, Q2 second quartile Q3 third quartile, Q4 fourth quartile, BMD bone mineral density, ALT alanine aminotransferase, AST aspartate aminotransferase, Cr creatinine, CRP C-reaction protein, BUN blood urea nitrogen, 25(OH)D 25-hydroxy vitamin D, BMI body mass index, CCI Charlson comorbidity index, OP osteoporosis, OPF osteoporotic fracture
  2. P-value*: Kruskal Wallis Rank Test for continuous variables, Fisher Exact for categorical variables with Expects < 10